A DTP Approach to Strengthening Type 1 Diabetes Care
The Digital Health Coalition Group recently hosted a panel discussion at GSK where ixlayer’s General Manager of Biopharma, Matthew Walsh, had the chance to present an example of a Direct to Patient (DTP) campaign aimed at improving the diagnostic journey for type 1 diabetes. Below, you can download the write-up to learn how this campaign created a seamless patient journey that addressed gaps in diagnosis and created a simplified connection to care.
CLICK HERE to learn more about how ixlayer works with biopharma leaders to integrate a complete end-to-end, direct-to-patient experience into their marketing campaigns.
About ixlayer
ixlayer is the only end-to-end, direct-to-patient platform built for biopharma and optimized for patient choice. We help biopharma companies connect with patients from testing to treatment with speed, transparency, control and impact.